title: [Antibody therapy in hematology and oncology--2].
authors.affiliation: II Medizinische Klinik und Poliklinik, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany. sekretariat@med2.uni-kiel.de
authors.forename: Michael
authors.initials: M
authors.lastname: Kneba
authors.forename: Carsten
authors.initials: C
authors.lastname: Schrader
authors.forename: Henning
authors.initials: H
authors.lastname: Köhne
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D000939:Epitopes / Q000276:immunology; D006801:Humans; D007938:Leukemia / Q000188:drug therapy* / Q000276:immunology; D008223:Lymphoma / Q000188:drug therapy* / Q000276:immunology; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D000939:Epitopes